These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 660591)

  • 1. A Fujita--Ban structure--activity analysis of 44 steroids.
    Justice JB
    J Med Chem; 1978 May; 21(5):465-8. PubMed ID: 660591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 11beta-hydroxysteroid dehydrogenase types 1 and 2: an important pharmacokinetic determinant for the activity of synthetic mineralo- and glucocorticoids.
    Diederich S; Eigendorff E; Burkhardt P; Quinkler M; Bumke-Vogt C; Rochel M; Seidelmann D; Esperling P; Oelkers W; Bähr V
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5695-701. PubMed ID: 12466373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological action of two glucocorticoid alkylating agents.
    El Masry AH; Braun VC; Nielsen CJ; Pratt WB
    J Med Chem; 1977 Sep; 20(9):1134-9. PubMed ID: 926113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of corticosteroids on host resistance to infection in relation to chemical structure.
    Fauve RM; Pierce-Chase CH
    J Exp Med; 1967 May; 125(5):807-21. PubMed ID: 4960741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative structure-activity relationships among steroids. Investigations of the use of steric parameters.
    Coburn RA; Solo AJ
    J Med Chem; 1976 Jun; 19(6):748-54. PubMed ID: 950640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationship of various corticosteroids on the feedback control of corticotrophin secretion.
    Jones MT; Tiptaft EM
    Br J Pharmacol; 1977 Jan; 59(1):35-41. PubMed ID: 189871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationship of some steroidal compounds in ocular inflammation.
    Ruggieri PD; La Macchia G; Rigamonti G; Sighinolfi O; Villa G
    Farmaco Sci; 1976 Dec; 31(12):849-55. PubMed ID: 1087906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and structure elucidation of potential 6-oxygenated metabolites of (22R)-6alpha,9alpha-difluoro-11beta,21-dihydroxy-1 6alpha,17alpha-propyl methylenedioxypregn-4-ene-3,20-dione, and related glucocorticosteroids.
    Thalén A; Wickström LI
    Steroids; 2000 Jan; 65(1):16-23. PubMed ID: 10624832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacological studies on butyl 6alpha-fluoro-11beta-hydroxy-16alpha-methyl-3,20-dioxo-1,4-pregnadien-21-oate (fluocortin butylester) (author's transl)].
    Kapp JF; Koch H; Töpert M; Kessler HJ; Gerhards E
    Arzneimittelforschung; 1977; 27(11a):2191-202. PubMed ID: 580028
    [No Abstract]   [Full Text] [Related]  

  • 10. [Studies on the Pharmacology of 6alpha,9-difluoro-11beta-hydroxy-16alpha-methyl-21-valeryloxy-1,4-pregnadiene-3,20-dione (diflucortolon valerate) (author's transl)].
    Kapp VJ; Koch H; Casals-Stenzel J; Töpert M; Gerhards E
    Arzneimittelforschung; 1976; 26(7b):1463-75. PubMed ID: 188428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A structural explanation of the effects of dissociated glucocorticoids on glucocorticoid receptor transactivation.
    Dezitter X; Fagart J; Taront S; Fay M; Masselot B; Hétuin D; Formstecher P; Rafestin-Oblin ME; Idziorek T
    Mol Pharmacol; 2014 Feb; 85(2):226-36. PubMed ID: 24225022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of physicochemical parameters and biological activity in steroids. 9Alpha-substituted corticol derivatives.
    Wolff ME; Hansch C
    Experientia; 1973 Sep; 29(9):1111-3. PubMed ID: 4744863
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of metopirone and glucocorticoids on the glycogen content in the adrenals of rat fetuses].
    Mitskevich MS; Rumiantseva ON
    Ontogenez; 1976; 7(6):638-42. PubMed ID: 1028013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity studies on hallucinogenic phenylalkylamines using Fujita-Ban approach.
    Bindal MC; Singh P; Gupta SP
    Arzneimittelforschung; 1982; 32(7):719-21. PubMed ID: 6889869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid Excess Increases Hepatic 11β-HSD-1 Activity in Humans: Implications in Steroid-Induced Diabetes.
    Dube S; Slama MQ; Basu A; Rizza RA; Basu R
    J Clin Endocrinol Metab; 2015 Nov; 100(11):4155-62. PubMed ID: 26308294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamics and pharmacokinetics of synthetic mineralocorticoids and glucocorticoids: receptor transactivation and prereceptor metabolism by 11beta-hydroxysteroid-dehydrogenases.
    Diederich S; Scholz T; Eigendorff E; Bumke-Vogt Ch; Quinkler M; Exner P; Pfeiffer AF; Oelkers W; Bähr V
    Horm Metab Res; 2004 Jun; 36(6):423-9. PubMed ID: 15241735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative structure-activity relationships. Fujita-Ban analysis of beta-adrenergic blocking activity of 1-phenoxy-3-([(substituted amido)alkyl]amino)-2-propanols.
    Gombar V
    Arzneimittelforschung; 1986 Jul; 36(7):1014-8. PubMed ID: 2876713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of 11-oxygenated steroids. Metabolism in vitro by preparations of liver.
    Bush IE; Hunter SA; Meigs RA
    Biochem J; 1968 Mar; 107(2):239-58. PubMed ID: 4384445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the pharmacology of 1,2-alpha-oxydo-androstan-3,17-dione (OAD).
    Linèt O; Háva M; Jakubovic A; Mikulásková J
    Arch Int Pharmacodyn Ther; 1965 Nov; 158(1):222-33. PubMed ID: 5854048
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.